Hormonal Carcinogenesis V
Information gathered from cell-free systems, cell cultures, animal models, and human studies, together will (1) provide important insights to our understanding of hormonal cancer causation, development, and prevention; (2) be the primary objective of thes
- PDF / 7,210,460 Bytes
- 647 Pages / 439.37 x 666.142 pts Page_size
- 43 Downloads / 171 Views
Proceedings of the Fifth International Symposium
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY Editorial Board: NATHAN BACK, State University of New York at Buffalo IRUN R. COHEN, The Weizmann Institute of Science ABEL LAJTHA, N.S. Kline Institute for Psychiatric Research JOHN D. LAMBRIS, University of Pennsylvania RODOLFO PAOLETTI, University of Milan
Recent Volumes in this Series Volume 610 TARGET THERAPIES IN CANCER Edited by Francesco Colotta and Alberto Mantovani Volume 611 PETIDES FOR YOUTH Edited by Susan Del Valle, Emanuel Escher, and William D. Lubell Volume 612 RELAXIN AND RELATED PETIDES Edited by Alexander I. Agoulnik Volume 613 RECENT ADVANCES IN RETINAL DEGENERATION Edited by Joe G. Hollyfield, Matthew M. LaVail, and Robert E. Anderson Volume 614 OXYGEN TRANSPORT TO TISSUE XXIX Edited by Kyung A. Kang, David K. Harrison, and Duane F. Bruley Volume 615 PROGRAMMED CELL DEATH IN CANCER PROGRESSION AND THERAPY Edited by Roya Khosravi-Far, and Eileen White Volume 616 TRANSGENIC MICROALGAE AS GREEN CELL FACTORIES Edited by Rosa León, Aurora Gaván, and Emilio Fernández Volume 617 HORMONAL CARCINOGENESIS V Edited by Jonathan J. Li
A Continuation Order Plan is available for this series. A continuation order will bring delivery of each new volume immediately upon publication. Volumes are billed only upon actual shipment. For further information please contact the publisher.
Jonathan J. Li • Sara A. Li • Suresh Mohla Henri Rochefort • Thierry Maudelonde Editors
Hormonal Carcinogenesis V
Jonathan J. Li, PhD University of Kansas Medical Center Department of Pharmacology Kansas City, KS, USA [email protected]
Sara A. Li, PhD University of Kansas Medical Center Department of Pharmacology Kansas City, KS, USA [email protected]
Henri Rochefort, MD/PhD Montpellier University and INSERM Hormone and Cancer Unit, U540 Montpellier, France henri.rochefort@valdorel. fnclcc.fr
Thierry Maudelonde, MD/PhD Department of Cell Biology Montpellier University 1-INSERM, U540 Hospital Arnaud de Villeneuve Montpellier, France t-maudelonde@ chu-montpellier.fr
ISBN: 978-0-387-69078-0 DOI: 10.1007/978-0387-69078-3
Suresh Mohla, PhD Division of Cancer Biology National Cancer Institute Rockville, MD, USA [email protected]
e-ISBN: 978-0-387-69078-3
Library of Congress Control Number: 2007938760 © 2008 Springer Science+Business Media, LLC All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to
Data Loading...
